Sunil Kumar Ahuja

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sunil K. Ahuja
Born 13 March 1961
Fields Genetics, immunology, molecular biology

Sunil Kumar Ahuja, M.D. (born March 13, 1961[1]) is a professor of Medicine, Microbiology, Immunology & Biochemistry at the University of Texas Health Science Center at San Antonio and an expert on the role of immunogenetics on HIV pathogenesis. Dr. Ahuja is also the Director of the Veterans Administration Research Center for AIDS and HIV-1 Infection. His most recent work, first published in the 2005 issue of Science, involves the ethnic group-specific role of CCR5 haplotype and CCL3L1 gene copy number on the progression of HIV to AIDS.[2]


Sunil Ahuja received his medical degree from the Armed Forces Medical College India in 1983.[3] Following work towards a M.Sc. degree from the University of Alberta in Canada, Dr. Ahuja had his internship and residency at the SUNY Health Science Center at Brooklyn.


Sunil Ahuja's research has been published in many high-profile peer-reviewed journals, including Science, Nature Medicine, Nature Immunology and Proceedings of the National Academy of Sciences.


Sunil Ahuja has been the recipient of many honors and awards, including being named in 2001 the Elizabeth Glaser Scientist and the Burroughs Wellcome Clinical Scientist in Translational Research.[4][5] In 2005 he also was the recipient of the MERIT award from the National Institutes of Health. Less than 5% of NIH-funded researchers receive this award.[5]

In February 2008 Dr. Ahuja was listed as one of 35 people that will shape our future by Texas Monthly magazine.[3]

Scientific disagreements[edit]

Some of Sunil Ahuja's work has been questioned by the scientific community. In July 2008 Sunil Ahuja's group reported that Duffy antigen receptor for chemokines (DARC (gene)) influenced HIV/AIDS susceptibility.[6] This finding was then questioned by four groups of scientists, reporting the failure to replicate.[7][8][9][10] Sunil Ahuja replied to the questioning in the same issue of Cell Host & Microbe.[11]


  1. ^ MDJunction, Accessed May 7, 2008
  2. ^ Science, Accessed April 11, 2008.
  3. ^ a b Texas Monthly, February 2008, Accessed April 11, 2008.
  4. ^ UTHSCSA News, January 12, 2001, Accessed April 11, 2008.
  5. ^ a b, HSC News, November 8, 2005, Accessed April 11, 2008.
  6. ^ He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK (2008). "Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility". Cell Host Microbe. 4 (1): 52–62. doi:10.1016/j.chom.2008.06.002. PMC 2562426Freely accessible. PMID 18621010. 
  7. ^ Walley NM, Julg B, Dickson SP, et al. (2009). "The Duffy Antigen Receptor for Chemokines Null Promoter Variant Does Not Influence HIV-1 Acquisition Or Disease Progression". Cell Host Microbe. 5 (5): 408–410. doi:10.1016/j.chom.2009.04.011. PMC 2720554Freely accessible. PMID 19454339. 
  8. ^ Winkler CA, An P, Johnson R, Nelson GW, Kirk G (2009). "Expression of Duffy antigen receptor for chemokines (DARC) has no effect on HIV-1 acquisition or progression to AIDS in African Americans". Cell Host Microbe. 5 (5): 411–413. doi:10.1016/j.chom.2009.04.010. PMID 19454340. 
  9. ^ Julg B, Reddy S, van der Stok M, et al. (2009). "Lack of Duffy Antigen Receptor for Chemokines: No Influence on HIV Disease Progression in an African Treatment Naïve Population". Cell Host Microbe. 5 (5): 413–415. doi:10.1016/j.chom.2009.04.009. PMC 2749504Freely accessible. PMID 19454341. 
  10. ^ Horne KC, Li X, Jacobson LP, et al. (2009). "Duffy antigen polymorphisms do not alter progression of HIV in African Americans in the MACS cohort". Cell Host Microbe. 5 (5): 415–417. doi:10.1016/j.chom.2009.04.013. PMID 19454342. 
  11. ^ "Author reply". Cell Host Microbe. 5: 418–419. 2009.